...
首页> 外文期刊>Clinical Pharmacology and Therapeutics >Side effects of opioids during short-term administration: effect of age, gender, and race.
【24h】

Side effects of opioids during short-term administration: effect of age, gender, and race.

机译:短期服用阿片类药物的副作用:年龄,性别和种族的影响。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Little is known about risk factors that increase the risk of development of opioid side effects. Our objective was to evaluate the effect of the type of opioid, age, gender, and race on the incidence of side effects from short-term opioid use. METHODS: A secondary analysis of a retrospective cohort study in 35 community-based and tertiary hospitals was done. There were 8855 black or white subjects aged 16 years and older. Patients received meperidine (INN, pethidine), morphine, or fentanyl as part of their treatment. Measurements were made to assess the presence of nausea and vomiting and respiratory depression. RESULTS: Of the patients, 26% had nausea and vomiting and 1.5% had respiratory depression after opioid administration. After adjustment for opioid dose, route of administration, age, gender, and race, meperidine produced less nausea and vomiting (odds ratio [OR] = 0.7; 95% confidence interval [CI], 0.5-0.8) and less respiratory depression (OR = 0.6; 95% CI, 0.2-0.9) than morphine. The risk of respiratory depression increased with age. Compared with patients aged between 16 and 45 years, those aged between 61 and 70 years had 2.8 times the risk of development of respiratory depression (95% CI, 1.2-6.6); those aged between 71 and 80 years had 5.4 times the risk (95% CI, 2.4-11.8); and those aged older than 80 years had 8.7 times the risk (95% CI, 3.8-20.0). Men had less nausea and vomiting than women (OR = 0.5; 95% CI, 0.4-0.6). White subjects had more nausea and vomiting than black subjects (OR = 1.4; 95% CI, 1.1-1.7). CONCLUSIONS: Meperidine produced fewer side effects than morphine during short-term use. The risk of respiratory depression increases substantially after 60 years of age. Women have nausea and vomiting more often than men. The effect of race deserves further investigation.
机译:目的:关于增加阿片类药物副作用发生风险的危险因素知之甚少。我们的目标是评估阿片类药物的类型,年龄,性别和种族对短期使用阿片类药物产生副作用的影响。方法:对35所社区和三级医院的回顾性队列研究进行了二次分析。共有8855名年龄在16岁以上的黑人或白人。患者接受哌替啶(INN,哌替啶),吗啡或芬太尼作为治疗的一部分。进行测量以评估恶心,呕吐和呼吸抑制的存在。结果:阿片类药物治疗后,有26%的人出现恶心和呕吐,有1.5%的人出现呼吸抑制。在调整了阿片类药物的剂量,给药途径,年龄,性别和种族之后,哌替啶产生的恶心和呕吐更少(几率[OR] = 0.7; 95%置信区间[CI]为0.5-0.8)和呼吸抑制(OR)更少=吗啡; 0.6%; 95%CI,0.2-0.9)。呼吸抑制的风险随年龄增长而增加。与年龄在16至45岁之间的患者相比,年龄在61至70岁之间的患者发生呼吸抑制的风险是后者的2.8倍(95%CI,1.2-6.6)。年龄在71至80岁之间的人的风险是其5.4倍(95%CI,2.4-11.8);而年龄超过80岁的人则是该风险的8.7倍(95%CI,3.8-20.0)。男性的恶心和呕吐次数少于女性(OR = 0.5; 95%CI,0.4-0.6)。白人受试者比黑人受试者有更多的恶心和呕吐(OR = 1.4; 95%CI,1.1-1.7)。结论:在短期使用中,哌替啶产生的副作用少于吗啡。 60岁以后,呼吸抑制的风险会大大增加。女人比男人更容易恶心和呕吐。种族的影响值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号